Literature DB >> 1974539

Effects of amino acids on glucose disposal.

G Boden1, L Tappy.   

Abstract

Free fatty acids are known to inhibit carbohydrate disposal and oxidation. This action may play an important role in the pathophysiology of insulin resistance and non-insulin-dependent diabetes mellitus. To investigate whether amino acids (AAs) have similar actions, we determined the effects of an intravenously infused mixture of 15 AAs on carbohydrate disposal during euglycemic-hyperinsulinemic clamps associated with either basal or high glucagon concentrations in healthy male volunteers. Plasma glucose concentration was clamped at approximately 4.7 mM (coefficient of variation 4.7%). Insulin infusion (7.18 pmol.kg-1.min-1) raised serum insulin concentrations from 36-50 pM to between 300 and 600 pM. AA infusions (0.5 g.kg-1.h-1.4 h) raised plasma alpha-amino N2 concentrations about five- to six-fold. Infusion of AAs, somatostatin (somatotropin release inhibitory factor, SRIF), and high-glucagon replacement (3.0 ng.kg-1.min-1) reduced the rate of exogenous glucose infusion needed to maintain euglycemia from 51.1 +/- 7.2 mumol.kg-1.min-1 (saline + SRIF + high glucagon) to 28.3 +/- 11.1 mumol.kg-1.min-1 and stimulated endogenous glucose production (from 0 to approximately 17 mumol.kg-1.min-1). Thus, glucose disposal (exogenous infusion plus endogenous production of glucose) remained essentially unchanged. During infusion of AAs + SRIF + basal glucagon replacement (0.25 ng.kg-1.min-1), endogenous glucose production remained completely suppressed, and the rates of exogenous glucose infusion did not change (compared with saline + SRIF + basal glucagon replacement). The data showed that 1) hyperaminoacidemia associated with hyperglucagonemia stimulated endogenous glucose production despite hyperinsulinemia, and 2) intravenous infusion of a mixture of 15 AAs had no inhibitory effect on insulin-stimulated total-body glucose disposal.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1974539     DOI: 10.2337/diab.39.9.1079

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

Review 1.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

2.  Quantitative proteomic analysis of S-nitrosated proteins in diabetic mouse liver with ICAT switch method.

Authors:  Xu Zhang; Bo Huang; Xixi Zhou; Chang Chen
Journal:  Protein Cell       Date:  2010-07-29       Impact factor: 14.870

3.  Ovarian suppression with a gonadotropin-releasing hormone agonist does not alter insulin-stimulated glucose disposal.

Authors:  Brian C Cooper; Cynthia K Sites; Peter R Casson; Michael J Toth
Journal:  Fertil Steril       Date:  2007-05       Impact factor: 7.329

4.  Amino acids are necessary for the insulin-induced activation of mTOR/S6K1 signaling and protein synthesis in healthy and insulin resistant human skeletal muscle.

Authors:  Micah J Drummond; Jill A Bell; Satoshi Fujita; Hans C Dreyer; Erin L Glynn; Elena Volpi; Blake B Rasmussen
Journal:  Clin Nutr       Date:  2008-03-14       Impact factor: 7.324

5.  Short-term regulation of insulin-mediated glucose utilization in four-day fasted human volunteers: role of amino acid availability.

Authors:  P J Flakoll; L S Wentzel; D E Rice; J O Hill; N N Abumrad
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

6.  Protein Ingestion Induces Muscle Insulin Resistance Independent of Leucine-Mediated mTOR Activation.

Authors:  Gordon I Smith; Jun Yoshino; Kelly L Stromsdorfer; Seth J Klein; Faidon Magkos; Dominic N Reeds; Samuel Klein; Bettina Mittendorfer
Journal:  Diabetes       Date:  2014-12-04       Impact factor: 9.461

7.  Effects of acute exposure to increased plasma branched-chain amino acid concentrations on insulin-mediated plasma glucose turnover in healthy young subjects.

Authors:  Sarah Everman; Lawrence J Mandarino; Chad C Carroll; Christos S Katsanos
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.